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Brain membrane preparations of different vertebrates were photoathnity labeled with PH]flunitrazepam and subsequently 
deglycosylated with endoglycosidase F and peptide N-glycopeptidase. SDS-polyacrylamide gel electrophoresis followed 
by fluorography revealed that each benzodiazepine-binding ‘protein is deglycosylated in two steps, indicating that each 
protein has two glycosylation sites. Species variation of the apparent molecular masses of the benzodiazepine-binding 
proteins and regional heterogeneity in avians persist after deglycosylation. These results indicate that the a-subunit(s) 
of the GABA/benzodiazepine receptor has undergone lectrophoretically detectable changes in its amino acid composi- 
tion during vertebrate volution. The existence of at least two different a-subunits in avians is further substantiated. 
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1. INTRODUCTION 
The GABA/benzodiazepine receptor (GABA/ 
BZR) presumably consists of two LY- and two P- 
subunits [l]. The homologous genes are members 
of a superfamily of ligand gated ion channels [2]. 
The a-subunit, which encompasses the ben- 
zodiazepine (BZ) binding site [3], is a glycoprotein 
containing two possible sites for glycosylation at 
the large N-terminal domain [2]. The carbohydrate 
moieties are indispensible for the correct formation 
of the receptor subunits in membranes [4]. They 
also influence the binding properties of the 
GABA/BZR [5]. 
Photoaffinity labeling of crude synaptic mem- 
branes with [3H]flunitrazepam (FNZ) followed by 
SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE) and fluorography revealed regional hetero- 
geneity of the BZ-binding proteins in rats [6]. A 
similar regional heterogeneity has been detected in 
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avians: In cerebellum mainly a protein of 53 kDa is 
detectable whereas in telencephalon an additional 
54 kDa band is labeled intensely [7,8]. Further 
phylogenetic studies have shown that a major BZ- 
binding protein of 55 kDa is labeled in several 
teleostean fishes [9]. Whereas we have hypothe- 
sized that multiple BZ-binding proteins within a 
single species represent different a-subunits of the 
GABA/BZR [lo], different glycosylation states of 
a single subunit could also account for these obser- 
vations [5]. In addition, species variation in the size 
of carbohydrate chains could also explain the 
phylogenetic differences observed. 
Here we compared the molecular masses of de- 
glycosylated BZ-binding proteins in different verte- 
brate species. For deglycosylation of BZ-binding 
proteins two enzymes were chosen, which reduce 
glycoproteins to carbohydrate-free proteins: endo- 
glycosidase F (endo F) removes most high mannose 
and some hybrid and complex oligosaccharides 
from glycoproteins; peptide N-glycosidase F 
(PNGase F) hydrolyses at the glycosylamine 
linkage and cleaves most types of N-linked carbo- 
hydrates [ 11,121. 
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SDS-PAGE and fluorography of deglycosylated BZ- 
binding proteins in fish. (a) Brain membranes of mackerel were 
photolabeled with [‘HIFNZ and subsequently deglycosylated 
with various concentrations of endo F. The completely de- 
glycosylated BZ-binding protein of 51 kDa in mackerel is of a 
slightly higher molecular mass than that of the two de- 
glycosylated BZ-binding proteins of 50 and 49 kDa in avian 
telencephalon (*). (b) [‘H]FNZ binding in the absence (1) and 
presence (2) of 3 yM clonazepam at 5 U/ml Endo F. In all 
species a diffuse band of 56 kDa was visible when the incuba- 
tion mixture contained endo F and to a considerably lesser ex- 
tent when PNGase F was used. To a slight extent, this band is 
also labeled nonspecifically (figs lc,2c,3c). Thus, it most likely 
does not represent a BZ-binding protein. In all figures numbers 
indicate apparent molecular masses (in kDa) which were 
calibrated with standard proteins. 
2. MATERIAL AND METHODS 
Mackerels were kindly provided by the Meeresbiologische 
Anstalt Helgoland. Jay, duck, pig and calf were obtained 
locally. 
[‘H]FNZ (spec. act. 81.8 Ci/mmol) was purchased from 
NEN; clonazepam was a kind gift from Hoffmann-La Roche 
(Basle). The enzymes endo F (EC 3.2.1.96) and PNGase F (EC 
3.2.2.18) were obtained from Boehringer (Mannheim). 
a b 
Brains were removed immediately after death or after 2 (pig) 
or 4 h (calf), subsequently frozen and stored at - 70°C. Mem- 
brane preparations including protease inhibitors and photoaf- 
finity labeling with [3H]FNZ were performed as described [9]. 
After photoaffinity labeling membranes were washed and re- 
suspended in 25 mM Tris-HCl (pH 7.4), containing 0.2% SDS 
(protein content 15-30 mg/ml). Then endo F (0.25-10 U/ml) or 
alternatively PNGase F (4.8-60 U/ml) was added and the mix- 
tures were incubated in a shaking water bath at 37°C for 18 h. 
Control samples without glycosidases were prepared under iden- 
tical conditions. SDS-PAGE was performed on 10% polyacryl- 
amide gels [9]. Gels were fixed, impregnated with Improved 
En3Hance (NEN), dried and exposed to Kodak X-Omat AR 
films for 2-4 weeks at - 70°C. 
3. RESULTS 
Addition of different concentrations of endo F 
to fish membrane preparations leads to degrada- 
tion of the photolabeled 55 kDa protein in two 
steps (fig.1). The molecular mass of the BZ- 
binding protein first decreases from 55 to 53 kDa 
and then finally to 51 kDa. 
In avian telencephalon deglycosylation of each 
of the two BZ-binding proteins seemingly also oc- 
curs in two steps. Both the 53 and 54 kDa proteins 
are first reduced to 51 kDa in jay and duck. This 
51 kDa band clearly appears as a doublet (fig.2a). 
Upon addition of higher endo F or PNGase F con- 
centrations two bands of 50 and 49 kDa are ap- 
parent, which cannot be further reduced (fig.2a,b). 
In duck and jay cerebella treatment with both 
glycosidases leads to a final degradation product of 
49 kDa. Application of lower enzyme concentra- 
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Fig.2. SDS-PAGE and fluorography of deglycosylated BZ-binding proteins in avians. (a) Deglycosylation patterns obtained with 
various concentrations of PNGase F in jay telencephalon. (b) Comparison of the deglycosylation patterns obtained with different con- 
centrations of endo F in membranes of jay telencephalon and cerebellum. (c) [‘H]FNZ binding in the absence (1) and presence (2) of 
3 PM clonazepam at 10 U/ml Endo F. 
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Fig.3. SDS-PAGE and fluorography of deglycosylated BZ-binding proteins in calf. Cortical (a) and cerebellar (b) membranes were 
photolabeled with 3H-FNZ and treated with various concentrations of endo F. (c) [3H]FNZ binding in the absence (1) and presence (2) 
of 3 pM clonazepam upon subsequent addition of 10 U/ml Endo F. 
tions also demonstrates a deglycosylation of the 
cerebellar 53 kDa protein in two steps via the inter- 
mediate degradation product of 51 kDa (fig.2b). 
In calf cerebellum a single BZ-binding protein of 
49 kDa is visible after deglycosylation with endo F 
(fig.3b) or PNGase F. Similar results were obtained 
in pig cerebellum. An immunoblot performed with 
the monoclonal antibody bd-24 specific for the cy- 
subunit [ 131 (kindly provided by Professor Mahler, 
Hoffmann-La Roche, Ba‘sle) revealed that at low 
glycosidase concentrations an intermediate de- 
glycosylation product of 51 kDa also exists in pig 
cerebellum (unpublished). Thus, the degradation 
patterns in avian and mammalian cerebella are 
similar. 
In cortices of pig and calf the main BZ-binding 
protein of 53 kDa is also deglycosylated in two 
steps by endo F and PNGase F to a final peptide of 
49 kDa. Fig.3a also shows that a faint 5 1 kDa band 
is still detectable at high endo F concentrations in 
mammalian cortices. In some original fluoro- 
graphics a BZ-binding protein of 59 kDa is weakly 
photolabeled in control samples. Upon de- 
glycosylation a weak specific band of 55 kDa is 
discernible. 
4. DISCUSSION 
Deglycosylation of BZ-binding proteins has 
previously been investigated in mammals only. 
Mamalaki and co-workers [l] also used endo F for 
deglycosylation of the purified bovine 
GABA/BZR; their labeling results with [3H]FNZ 
are similar to ours in calf and pig cortex. Treatment 
of rat hippocampal membranes with endo F or 
PNGase F modified the apparent molecular masses 
of the two major BZ-binding proteins labeled in 
this region [ 141. The results described by Sweetnam 
and Tallman [5] in rat cortex differ from ours, 
however, these investigators used neuraminidase 
and endo H, which removes N-linked mannose- 
rich carbohydrates and certain hybrid oligosac- 
charides from glycoproteins. 
Our deglycosylation patterns are similar in all 
species and brain regions investigated. Each 
original BZ-binding glycoprotein is degraded in 
two steps: low glycosidase concentrations ap- 
parently cleave a carbohydrate moiety of 2-3 kDa, 
higher concentrations induce a further cleavage of 
an additional carbohydrate chain of similar 
molecular mass. Since the cleavage process is clear- 
ly dependent on glycosidase concentrations, it is 
essential to apply these enzymes generously in 
order to obtain carbohydrate-free BZ-binding pro- 
teins. 
The degradation of BZ-binding proteins in two 
steps points to the presence of two glycosylation 
sites on each individual protein. Apparently, the 
respective cleavage sites differ in their accessibility 
for glycosidases. It thus appears that both potential 
glycosylation sites on the bovine a-subunit [2] are 
indeed glycosylated. Furthermore, the molecular 
mass of the final deglycosylation product of the 
53 kDa protein in our experiments is very similar to 
that evaluated for the amino acid chain of the CY- 
subunit (48.8 kDa). 
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The general accordance of our results with those 
obtained by Schofield et al. [2] facilitates the inter- 
pretation of our deglycosylation studies: the two 
glycosylation sites are phylogenetically conserved, 
since degradation occurs in two steps in each 
species examined. The phylogenetic differences in 
molecular mass of the original labeling patterns 
persist after deglycosylation, e.g. the carbo- 
hydrate-free BZ-binding protein in teleostean 
fishes has a higher molecular mass than its counter- 
part in mammals. Thus, the phylogenetic variation 
in molecular mass of the BZ-binding proteins is 
seemingly due to different amino acid composi- 
tions . 
The presence of two or more photolabeled 
bands within a single species is of great interest, 
since they possibly represent additional a-subunits, 
thus rendering the GABA/BZR an isoreceptor 
complex [lo]. Avians are .especially suited for an 
assessment of regional and ontogenetic variation of 
labeling patterns [7,8]. The 54 kDa band was 
shown to be clearly distinct from the P-subunit in 
chickens [ 11. Our deglycosylation studies apparent- 
ly exclude the possibility that the 53-54 kDa bands 
are the result of different glycosylation states of a 
single subunit. Instead, the presence of two distinct 
deglycosylated BZ-binding proteins in avians fur- 
ther substantiates the existence of at least two (Y- 
subunit-specific genes, which are differentially ex- 
pressed according to regional and ontogenetic re- 
quirements. 
In mammals mainly the 53 kDa band is fluoro- 
graphically visualized using our labeling condi- 
tions. In cortices additional faint bands of 56 and 
59 kDa are apparent [ 151. These bands are seem- 
ingly further decreased in intensity in the controls 
for the deglycosylation studies. Thus, the labeling 
patterns in mammalian cortices do not allow a 
clear-cut answer as to the degradation of the 56 and 
59 kDa band upon glycosidase treatment. How- 
ever, in hippocampus differences in the molecular 
mass of BZ-binding proteins also persist after de- 
glycosylation [ 141. 
In view of the labeling results obtained in avians, 
the 53 kDa band in mammals could conceivably 
consist of the combined labeling intensity of two 
proteins comigrating upon SDS-PAGE. If this is 
the case, one of the two proteins is possibly more 
readily totally deglycosylated than the other as sug- 
gested by the 4-fold difference in glycosidase con- 
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centrations required to degrade completely the 
cerebellar and cortical 53 kDa band. Immunoblots 
performed with the a-subunit specific monoclonal 
antibody bd-24 have revealed similar degradation 
patterns to those observed upon photoaffinity 
labeling (unpublished). 
In summary, after complete deglycosylation of 
BZ-binding proteins species variation and regional 
heterogeneity are still detectable, thus supporting 
the hypothesis that multiple a-subunits exist which 
have evolved by gene duplication and subsequent 
divergence [10,161. We conclude that phylogenetic 
and regional multiplicity of the photolabeled BZ- 
binding proteins are not based on different 
glycosylation states but on differences in the length 
of the respective amino acid chain. 
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